Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +56.03%
#3 Glidr Glidr +38.25%
#4 Cysic Cysic +31.67%
#5 Walrus Walrus +25.97%
#6 Humanity Humanity +20.80%
#7 Tutorial Tutorial +17.00%
#8 Enso Enso +15.98%
#9 Velvet Velvet +15.00%
#10 Huma Finance Huma Finance +13.59%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Kedudukan dalam Saham #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Harga Saham
$0.069
Disegerakkan terakhir: 2024-07-22
Modal Pasaran
$2.06M
Perubahan (1 hari)
-1.43%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan DermTech, Inc. (DMTK)

Kategori

Healthcare
Nisbah P/S bagi DermTech, Inc. (DMTK)
Nisbah P/S pada August 2026 TTM: 0.21
Menurut laporan kewangan dan harga saham terkini DermTech, Inc., nisbah P/S semasa (TTM) ialah 0.21. Pada akhir 2022, nisbah P/S syarikat ialah 3.66.
Sejarah nisbah P/S untuk DermTech, Inc. dari 2016 hingga 2026
Nisbah P/S pada akhir setiap tahun
Tahun Nisbah P/S Ubah
2026 (TTM) 0.21 -93.93%
2023 3.54 -3.27%
2022 3.66 -90.50%
2021 38.55 -58.81%
2020 93.59 262.47%
2019 25.82 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
Nisbah P/S untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/S Perbezaan Nisbah P/S Negara
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
4.72 2,095.53%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
5.67 2,537.74%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
16.40 7,529.83%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
9.55 4,341.69%
US